Hinweis-Modus ist eingeschaltet Ausschalten

FXH - First Trust Health Care AlphaDEX Fund (USD) (US33734X1431)

The comparsion limit has been reached: only 5 tools has been added. To add a new one, please remove one of the existing tools.
 
(%)
US33734X1431
FXH ISIN
Exchange Traded Funds (ETF)
Fondstyp
First Trust
Anbieter
122,57 USD
NAV pro Aktie | 15/07/2026
08/05/2007
Startdatum
4 Wiederholungen pro Jahr
Ausschüttung von Dividenden
CEOJLS
CFI
FXH
Ticker
Formed
Status
Equity
Investitionsobjekt
Healthcare
Sektor
USA
Geographie
StrataQuant(R) Health Care Index.
Benchmark
0.62 %
Gesamtkostenquote
1.005,07 Mio. USD
Gesamtes Fondsvermögen | 15/07/2026
1.005,07 Mio. USD
Aktien-Anlageklasse Volumen | 15/07/2026
Nein
UCITS

Rendite auf 15/07/2026, NYSE Arca

  • YTD
    -1,11 %
  • 1M
    -1,3 %
  • 3M
    -1,89 %
  • 6M
    1,42 %
  • 1J
    10,58 %
  • 3J
    8,75 %
  • 5J
    2,21 %
  • 10J
    101,62 %
Zum Börsenpreis einschliesslich Einkommenszahlungen

Letzte Daten zum
Zum Vergleichen hinzufügen

Kurse (FXH)

Entdecken Sie die umfangreichste Datenbank

1 000 000

Anleihen weltweit

100 000

Aktien

175 910

ETF & Funds

100 000

Indizes

Verwalten Sie Ihr Portfolio auf effizienteste Weise

  • Bond-Screener
  • Watchlist
  • Excel-Add-In

Kurs-Dynamik

FXH profile

The First Trust Health Care AlphaDEX Fund (USD) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in USA. The First Trust fund’s base currency is USD and the share class was registered 08.05.2007 with unique ISIN - US33734X1431. Main exchange is NYSE Arca and ticker symbol is FXH. The total expense ratio is 0.62%. The First Trust Health Care AlphaDEX Fund (USD) pays dividends 4 time(s) per year.

Struktur FXH auf 15/07/2026

Wertpapier Wertpapier
Guardant Health, Inc. 2,55%
The Cigna Group 2,53%
Regeneron Pharmaceuticals, Inc. 2,5%
Zimmer Biomet Holdings, Inc. 2,46%
DaVita Inc. 2,44%
Centene Corporation 2,43%
Pfizer Inc. 2,42%
Natera, Inc. 2,4%
Solventum Corporation 2,38%
Boston Scientific Corporation 2,37%
Medline Inc. (Class A) 2,35%
Universal Health Services, Inc. (Class B) 2,34%
Globus Medical, Inc. (Class A) 2,33%
Axsome Therapeutics, Inc. 2,28%
Encompass Health Corporation 1,9%
QIAGEN N.V. 1,85%
Zoetis Inc. 1,82%
Corcept Therapeutics Inc. 1,8%
Tenet Healthcare Corporation 1,8%
Medtronic Plc 1,8%
Neurocrine Biosciences, Inc. 1,79%
Incyte Corporation 1,78%
ResMed Inc. 1,78%
Elevance Health Inc. 1,77%
Ascendis Pharma A/S 1,76%
United Therapeutics Corporation 1,72%
Halozyme Therapeutics, Inc. 1,7%
Eli Lilly and Company 1,69%
Arrowhead Pharmaceuticals, Inc. 1,54%
Doximity, Inc. (Class A) 1,51%
Viatris Inc. 1,48%
Gilead Sciences, Inc. 1,47%
Becton, Dickinson and Company 1,44%
Exelixis, Inc. 1,44%
Bristol-Myers Squibb Company 1,43%
Steris Plc 1,41%
Medpace Holdings, Inc. 1,41%
GE HealthCare Technologies Inc. 1,39%
Revolution Medicines, Inc. 1,39%
Labcorp Holdings Inc. 1,37%
Quest Diagnostics Incorporated 1,34%
Biogen Inc. 1,28%
Ionis Pharmaceuticals, Inc. 0,97%
BridgeBio Pharma, Inc. 0,97%
Veeva Systems Inc. (Class A) 0,96%
Align Technology, Inc. 0,94%
IQVIA Holdings Inc. 0,94%
Thermo Fisher Scientific Inc. 0,94%
Chemed Corporation 0,93%
Henry Schein, Inc. 0,91%
Madrigal Pharmaceuticals, Inc. 0,9%
Agilent Technologies, Inc. 0,89%
Tempus AI, Inc. (Class A) 0,87%
Organon & Co. 0,87%
Abbott Laboratories 0,86%
AbbVie Inc. 0,85%
HCA Healthcare, Inc. 0,85%
Vertex Pharmaceuticals Incorporated 0,84%
DexCom, Inc. 0,47%
Illumina, Inc. 0,47%
IDEXX Laboratories, Inc. 0,46%
The Ensign Group, Inc. 0,46%
Danaher Corporation 0,46%
BioMarin Pharmaceutical Inc. 0,45%
Bio-Rad Laboratories, Inc. (Class A) 0,44%
Envista Holdings Corporation 0,44%
Revvity, Inc. 0,44%
Stryker Corporation 0,44%
West Pharmaceutical Services, Inc. 0,44%
The Cooper Companies, Inc. 0,43%
Johnson & Johnson 0,43%
Amgen Inc. 0,43%
Merck & Co., Inc. 0,42%
US Dollar 0,21%
Andere - %

Andere ETFs und Fonds dieses Anbieters

Ähnliche Etf & Fonds

  • {{ item.etf.ttl }}
    {{ item.nav_usd }} Mio.
    NAV
    {{ item.expense_ratio }}
    Gesamtkostenquote
Sie müssen sich registrieren , um Zugriff zu erhalten.